Abstract
A PROSPECTIVE OBSERVATIONAL STUDY ON PERCEPTION ABOUT COVID-19 IMMUNIZATION

Nikitha K.*, Ambika M. S. and Dr. Rosy Raju

ABSTRACT

Vaccination is a process of immunization and an foremost form of primary prevention which protect people from getting sick. It has pulled the stings of the diseases that has intimidated human existence. The immune system is comprised of several types of cells, which recognise and defends against the invaders. Vaccination instruct the body to identify new diseases and stimulates the body to make antibodies against antigens of pathogens. It also paramount immune cells to remember the types of antigens that cause infection and allows for a quicker response to the disease in future. When the body responds to the vaccine, it mould an adaptive immune response which provide the body to fight off an actual infection. Vaccines are generally given as injection. The bulk of research and corroboration proves that vaccines are safe and side effects are rare. They are attentively tested and passed through many rounds of study, examination, and research before they reaches the general public. Side effects that do occur are typically mild. As a matter of fact, the greatest risk is not to get a vaccine and potentially get sick and could even be deadly. Covid 19 respiratory infectious deadly disease caused by novel corona virus which have taken many lives. The aim of this prospective observational study was to ascertain the myth and fact about Covid 19 vaccination among 140 common people.

Keywords: Immunization, COVID vaccination, Myth and facts.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT